The FDA has issued an updated guideline for drug warning labels, is considering lifting a blood donation ban, and has approved several new treatment options.
<p>The U.S. Food and Drug Administration changed the rules governing how prescription drugs and biologics used during pregnancy and breastfeeding are labeled.</p>
Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with meningitis B, hemophilia A, and non-valvular atrial fibrillation.
The FDA granted fast track priority review and approved two new treatments for idiopathic pulmonary fibrosis ahead of originally intended approval dates.
